Interleukin-1β up-regulates nitrite production: Effects on ovarian function

Nitric Oxide - Biology and Chemistry

Volumn 10, Issue 2, 2004, Pages 92-100

  Estevez A ^a   Farina, M ^a   Franchi, A ^a   Johnson, C ^b   Vega, M ^b   Motta, A B ^a  

^a Ctr for Pharmacol and Bot Studies   (Argentina)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PROGESTERONE; INTERLEUKIN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; DRUG EFFECT; DRUG PROTEIN BINDING; ENZYME ACTIVATION; EXPLANT; FEMALE; INCUBATION TIME; NONHUMAN; OVARY FUNCTION; PRIORITY JOURNAL; PROGESTERONE RELEASE; RAT; STEROIDOGENESIS; UPREGULATION; ANIMAL; BIOSYNTHESIS; CHEMISTRY; METABOLISM; OVARY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; FEMALE; INTERLEUKIN-1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OVARY; PROGESTERONE; RATS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 2342579393     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2004.02.004     Document Type: Article

References (52)

1. Duncan W.C., Rodger F.E., Illingworth P.J. The human corpus luteum: reduction in macrophages during simulated maternal recognition of pregnancy. Hum. Reprod. 13:1998;2435-2442
2. Brännström M., Giesecke L., Moore I.C., Van Del Heuvel C.J., Robertson S.A. Leukocyte subpopulations in the rat corpus luteum during pregnancy and pseudopregnancy. Biol. Reprod. 50:1994;1161-1167
3. Sugino N., Shimamura K., Tamura H., Ono M., Nakamura Y., Ogino K., Kato H. Progesterone inhibits superoxide radical production by mononuclear phagocytes in pseudopregnant rats. Endocrinol. 137:1996;749-754
4. Bagavandoss P., Wiggins R.C., Kunkel S.L., Remick D.G., Keyes P.L. Tumor necrosis factor production and accumulation of inflammatory cells in the corpus luteum of pseudopregnancy and pregnancy in rabbits. Biol. Reprod. 42:1990;367-376
5. Adashi E. The potential relevance of cytokines to ovarian physiology: the emerging role of residant ovarian cells of the white blood cell series. Endocr. Rev. 11:1990;454-464
6. Kohen P., Castro A., Caballero-Campo E., Castro O., Vega M., Makrigiannakis A., Simon C., Carvallo P., Devoto L. Interleukin-1β is a modulator of human cell steroidogenesis: localization of the IL type I system in the corpus luteum. J. Clin. Endocrinol. Metab. 84(11):1999;4239-4245
7. Hurwitz A., Ricciarelli E., Botero L., Katz E., McAllister J.M., García J.E., Loukides J., Rohan R.M., Adashi E.Y. The human intraovarian interleukin-1 (IL-1) system: highly compartmentalized and hormonally-dependent regulation of the genes encoding IL-1, its receptor, and its receptor antagonist. J. Clin. Invest. 129:1991;3427-3429
8. Simón C., Francés A., Piquete G., Polan M.L. Immunohistochemical localization of the interleukin-1 system in the mouse ovary during follicular growth, ovulation and luteinization. Biol. Reprod. 50:1994;449-457
9. Wang C., Branstrom M., Cui K.H., Simula A.P., Hart R.P., Maddocks S., Norman R.J. Localization of mRNA for interleukin-1 receptor and interleukin-1 receptor antagonist in the rat ovary. J. Endocrinol. 152:1997;11-17
10. Donesky B.W., Dia sde Moura M., Tedeschi C. Interleukin-1β inhibits steroidogenic bioactivity in cultured rat ovarian granulosa cells by stimulation of progesterone degradation and inhibition of estrogen formation. Biol. Reprod. 58(5):1998;1108-1116
11. Best C.L., Hill J.A. Interleukin-1 α and β modulation of luteinized human granulosa cell estrogen and progesterone biosynthesis. Hum. Reprod. 10(12):1995;3206-3210
12. Brännström M., Norman R.J. Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function. Hum. Reprod. 8:1993;1762-1775
13. Narko K., Ritvos O., Ristmaki A. Induction of Cyclooxygenase-2 and Prostaglandin F2α receptor expression by Interleukin-1β in cultured Human Granulosa-Luteal Cells. Endocrinol. 138:1997;3638-3644
14. Townson D.H., Pate J.L. Regulation of prostaglandin synthesis by interleukin-1 in cultured bovine luteal cells. Biol. Reprod. 51:1994;480-485
15. Ellman C., Corbet J.A., Misko T.P., Mc Daniel M., Beckerman K.P. Nitric oxide mediates interleukin-1β induced cellular cytotoxicity. A potential role for nitric oxide in the ovulatory process. J. Clin. Invest. 92:1993;3053-3056
16. Peterson C.M., Hales H.A., Hatasaka H.H., Mitchell M.D., Rittenhouse L., Jones K.P. Interleukin-1 β (IL-1β) modulates prostaglandin production and the natural IL-1 receptor antagonist inhibits ovulation in the optimally stimulated rat ovarian perfusion model. Endocrinol. 133:1993;2301-2306
17. Estévez A., Tognetti T., Rearte B., Sander V., Motta A. Interleukin-1β in the functional and structural luteolysis: relationship with the nitric oxide system. Prostagl. Leukotr. Essent. Fat. Ac. 67(6):2002;411-417
18. A. Estévez, T. Tognetti, B. Rearte, V. Sander, A. Motta, Sequence of Interleukin-1β actions on corpus luteum regression: relationship with inducible cyclooxygenase and nitric oxide synthase expressions, Reprod. (2003) (REP 311, Nov. in press)
19. Friden B.E., Runesson E., Hahlin M., Brannstrom M. Evidence for nitric oxide acting as a luteolytic factor in the human corpus luteum. Mol. Hum. Reprod. 6(5):2000;397-403
20. Shukovski L., Tsafriri A. The involvement of NO in the ovulatory process in the rat. Endocrinol. 135:1994;2287-2290
21. Johnson M.C., Diaz H.A., Stocco C., Palomino A., Devoto L., Vega M. Antisteroidogenic action of nitric oxide on human corpus luteum in vitro. Endocrine. 11(1):1999;31-36
22. Van Voorhis B.J., Dunn M.S., Snyder G.D., Weiner C.P. Nitric oxide: an autocrine regulator of human granulosa luteal cells steroidogenesis. Endocrinol. 135:1994;1799-1806
23. Olson M.L., Jones-Burton C.H.M., Jablonka-Shariff A. Nitric oxide decreases estradiol synthesis of rat luteinized ovarian cells: possible role of nitric oxide in functional luteal regression. Endocrinol. 137:1996;3531-3539
24. Vega M., Johnson M.C., Diaz H.A., Urrutia L.R., Troncoso J.L., Devoto L. Regulation of human luteal steroidogenesis in vitro by nitric oxide. Endocrine. 8(2):1998;185-191
25. Motta A.B., Estévez A., Gimeno M.A.F. The involvement of nitric oxide in corpus luteum regression in the rat:feedback mechanism between prostaglandin F2α and nitric oxide. Mol. Hum. Reprod. 5:1999;1011-1016
26. Moncada S., Higgs A. The arginine-nitric oxide pathway. N. Eng. J. Med. 329:1993;2002-2012
27. Motta A.B., Estévez A., Franchi A., Perez-Martinez S., Farina M., Ribeiro M.L., Lasserre A., Gimeno M.A.F. Regulation of lipid peroxidation by nitric oxide and PGF2α during luteal regression in rats. Reproduction. 121:2001;631-637
28. Green L.C., Wagner D.A., Glowgowski J., Skepper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal. Biochem. 124:1982;131-138
29. Chromczynki P., Sacchi N. Single step method of RNA isolation by acid guanidium thiocynate-phenol-chloroform extraction. Anal. Biochem. 162:1997;156-159
30. Johnson M.C., Vega M., Vantman D. Regulatory role of angiotensin II on progesterone production by cultured human granulosa cells. Expression of angiotensin II type 2 receptor. Mol. Hum. Reprod. 3:1997;663-668
31. Bradford M.M. A rapid sensitive method for the quantification of protein dye binding. Anal. Biochem. 72:1976;248-254
32. Niswender G.D., Juengel J.L., Silva P.J., Rollyson M.K., McIntush E.W. Mechanisms controlling the function and the life span of the corpus luteum. Physiol. Rev. 80:2000;1-29
33. Duncan W.C. The human corpus luteum:remodelling during luteolysis and maternal recognition of pregnancy. Rev. Reprod. 5:2000;12-17
34. Dawood M.Y., Chellaram R., Khan-Dawood F.S. Interleukin-1β inhibits in vitro pulsatile progesterone secretion and stimulates prostaglandin F2α secretion by micro-retrodialized baboon corpus luteum. Horm. Metab. Res. 29(10):1997;483-490
35. Ignarro L.J., Fukuto J.M., Griscavage J.M., Rogers N.E., Byrns R.E. Oxidation of nitric oxide in aqueous solution to nitrite but not to nitrate: comparison with enzymatically-formed nitric oxide from L-Arginine. Proc. Natl. Acad. Sci. USA. 90:1993;8103-8107
36. Ben Shlomo I., Kokia E., Jackson M., Adashi E.Y., Payne D.W. Interleukin-1β stimulates nitrite production in the rat ovary: evidence for heterologous cell-cell interaction and for insulin-mediated regulation of the inducible isoform of nitric oxide synthase. Biol. Reprod. 54:1994;436-445
37. Kwon S., Newcomb R.L., George S.C. Mechanism of synergistic cytokine-induced nitric oxide production in human alveolar epithelial cells. Nitric Oxide. 5:2001;534-546
38. Roberts A.B., Vodovotz Y., Roche N.S., Sporn M.B., Nathan C.F. Role of nitric oxide in antagonistic effects of transforming growth factor-β and interleukin-1 on the beating rate of cultured cardiac myocytes. Mol. Endocrinol. 6:1992;1921-1930
39. Tao Meng, Kodama Hideya, Kagabu Satoko, Fukuda Jun, Murata Masanori, Shimizu Yasushi, Hirano Hideto, Tanaka Toshinobu Possible contribution of follicular interleukin-1β to nitric oxide generation in human pre-ovulatory follicles. Hum. Reprod. 12(10):1997;2220-2225
40. Jaroszewski J.J., Bogacki M., Skarzynsky D.J. Progesterone production in bovine luteal cells treated with drugs that modulate nitric oxide production. Reproduction. 125(3):2003;389-395
41. Snyder S.H. Nitric oxide: first in a new class of neurotransmitters? Science. 257:1992;494-496
42. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142
43. Ignarro J.L. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30:1990;535-560
44. Thomson A.J., Lunan B.C., Cameron A.D., Cameron I.T., Greer I.A., Norman J.E. Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial. Br. J. Obstet. Gynaecol. 104:1997;1054-1057
45. Barroso R.P., Osuamkpe C., Nagamani M., Yallampalli C. Nitric Oxide inhibits development of embryos and implantation in mice. Mol. Hum. Reprod. 4:1998;503-507
46. Rosselli M., Dubey R.K., Imthurn B., Macas E., Keller P.J. Effects of nitric oxide on human spermatozoa-evidence that nitric oxide decreases sperm motility and induces sperm toxicity. Hum. Reprod. 10:1995;1786-1790
47. Motta A.B., Gimeno M.A.F. Nitric oxide participates in the corpus luteum regression in ovaries isolated from pseudopregnant rats. Can. J. Physiol. Pharmacol. 75:1997;1335-1339
48. Van't Hof R.J., Armour K.J., Smith L.M., Armour K.E., Wei X.Q., Liew F.Y., Ralston S.H. Requirement of inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption. Proc. Natl. Acad. Sci. USA. 97(14):2000;7993-7998
49. Garvey E.P., Oplinger J.A., Furfine E.S., Kiff R.J., Laszlo F., Whittle J.R., Knowles R.G. 1400W is a slow, tight binding and highly selective inhibitor of inducible nitric oxide synthase in vitro and in vivo. J. Biol. Chem. 272(8):1997;4959-4963
50. Takii T., Hayashi M., Marunouchi T., Onozaki K. Interleukin-1 dow-regulates type I interleukin-1 receptor mRNA expression in a human fibroblast cell line TIG-1 in the absence of prostaglandin E2 synthesis. Lymphokine Cytokine Res. 13(3):1994;213-219
51. McGee D.W., Vitkus S.J., Lee P. The effect of cytokine stimulation on IL-1 receptor mRNA expression by intestinal epithelial cells. Cell. Immunol. 168(2):1996;276-280
52. Huang H.Y., Wen Y., Valbuena D., Krussel J.S., Polan M.L. Interleukin-1 β regulates Vero cell interleukin-1 receptor type I messenger ribonucleic acid expression. Biol. Reprod. 57(4):1997;783-790